Summary by Moomoo AI
SenesTech, a company specializing in the development and commercialization of fertility control products, reported a net loss of $4.9 million for the nine months ended September 30, 2024, with a net loss of $1.5 million for the third quarter of the same year. Despite the losses, the company saw a 51% increase in revenue year-over-year for the nine-month period, reaching $1.356 million, driven by the launch of their latest Evolve product offerings. The company's gross profit margin improved to 51.5% for the nine months ended September 30, 2024, compared to 45.6% for the same period in 2023. Research and development expenses increased slightly, while selling, general, and administrative expenses decreased due to lower personnel-related expenses and professional fees. SenesTech continues to focus on the commercialization of...Show More
